Western Institutional Review Board (WIRB)

Western IRB (WIRB), an independent commercial IRB located in Olympia, WA, has been contracted to act as one of Rutgers Health Sciences's IRBs to review, approve and monitor industry-sponsored human subjects research.

All submissions to WIRB must go through the RHS Institutional Review Board.

Notice of Recent Documentation Changes – August 2014 updates

Beginning September 1, 2014, there will no longer be a Board Chair signature on WIRB's letters that further outline decisions made by the Board. There is no regulatory requirement of this signature. The exception to this rule will be correspondence outlining the Board's decision on Waivers from HIPAA and certain Canadian correspondence where signatures are required.

WIRB is eliminating this signature as a small part of its renewed commitment to efficiency and customer service. As always, we remain devoted to meeting the highest standards of regulatory compliance.

Criteria for submission of studies for review by WIRB

  • Study is industry-sponsored, that is, the industry sponsor has written the protocol, is funding the research, and will monitor the conduct of the study.
  • The research will be conducted at a Rutgers performance site. (Site is owned and operated by Rutgers)
  • The investigator(s) is (are) Rutgers employees
  • The investigator(s) is (are) in good standing with the Rutgers Health Sciences IRB (e.g., no compliance issues, no expired studies, etc.)
  • All study personnel involved in human subjects research have completed the Collaborative Institutional Training Initiative (CITI) Basic Course.

Circumstances Requiring Review of Protocols by a Rutgers Health Sciences IRB

Under the following circumstances, protocols may not be reviewed by WIRB, but must be reviewed by a Rutgers Health Sciences IRB:

  • the research will be conducted at a non-Rutgers performance site (such as a CINJ-affiliated site, VA affiliates, etc.).
  • the research will have or could be perceived as having significant local impact on the University’s host communities, requiring special sensitivity to the University’s host communities’ attitudes and culture, and/or sufficient knowledge of the local research context.
  • the research will be conducted by investigators who have current compliance issues or are otherwise not in good standing with a Rutgers Health Sciences IRB.
  • research requiring Institutional Biosafety oversight, such as research involving the following:
    • Infectious agents,
    • Recombinant DNA/human gene transfer,
    • or Biologically-derived toxins